Can a daily powder improve your face and body? new study tests High-Dose hyaluronan
NCT ID NCT07583108
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study will test whether taking a high dose of oral hyaluronan (HA35) daily for 40 days can reduce facial fullness, double chin, skin redness, and improve skin vitality and body weight. Thirty adults seeking non-invasive aesthetic improvement will participate. The study is open-label and single-arm, meaning everyone gets the treatment and knows it.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
oral 35 kDa hyaluronan (HA35)
What this could lead to
If it works, this could offer a non-invasive, oral option for improving facial contour and skin appearance.
What could go wrong
This is a very small, early pilot study with only 30 participants and no placebo group, so results may not be reliable or generalizable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FACIAL SUBCUTANEOUS FULLNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.